Need a Reliable Peptide Supplier? Click HERE!!!SponsoredVisit ↗
Vesugen and BAC Water Mix

Vesugen Reconstitution Calculator

Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.

What amount do you need?

Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.

Work the dose out from body weight

Syringe size:
Possible vial strengths:
Best Match Good Match Usable Harder to Measure

Example Vesugen Titration Schedule

ItemDetails
Standard dose0.5–1 mg once daily
Courses10–20 days, 2–3× per year
Originator dose10–1000× lower (Russian tradition)

Four small Russian studies (none placebo-controlled); one showed pro-oxidant activity plus reduced CD34+ stem cells in elderly. The '1–5 mg per dose' figure is a recurring placeholder that never matched a validated protocol for any bioregulator; sources disagree up to 1000× on real doses.

Possible vial strengths:

What Is It?

Vesugen

Vascular peptide bioregulator.

Bacteriostatic Water

Sterile water containing a bacteriostatic preservative, commonly used when preparing multi-use research vials.

How To Mix Vesugen

1
Clean

Use alcohol swabs to clean the tops of both vials.

2
Draw BAC Water

Draw the selected amount of bacteriostatic water.

3
Inject Slowly

Add the liquid slowly down the side of the vial.

4
Swirl Gently

Do not shake. Swirl gently until dissolved.

5
Store Properly

Store as directed and protect from heat and light.

Best Practices & Common Mistakes

Best Practices

  • Use sterile technique.
  • Protect from light and heat.
  • Store refrigerated when appropriate.
  • Use clean syringe-unit math before measuring.

Common Mistakes

  • Confusing milligrams with milliliters.
  • Choosing an option with awkward decimal units.
  • Using too little liquid for very small measurements.
  • Shaking the vial aggressively.

Vesugen Storage & Handling

Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.

Frequently Asked Questions

Vesugen is a Khavinson "bioregulator" — a synthetic tripeptide (Lys-Glu-Asp, or KED) developed in Russia to target the endothelial cells lining blood vessels at the gene level. It comes in oral capsule, sublingual, and research-grade injectable forms. The proposed idea is that this short peptide helps normalize vascular function rather than acting like a conventional cardiovascular drug.
Vesugen (KED) is the synthetic vascular tripeptide, while Ventfort is the natural vascular extract version — same target tissue, different source. It's also distinct from its siblings by target: Cardiogen is for heart muscle, and the near-identical KEDA (Livagen) is for the liver, so the tiny sequence change is what supposedly redirects the tissue focus. These are often stacked in Khavinson protocols but are not interchangeable.
In lab and Russian clinical reports, Vesugen is described as normalizing endothelial markers (like endothelin-1), activating SIRT1, and improving arterial blood flow in aging vessels. It's one of the better-published Khavinson peptides, but the evidence is still predominantly Russian, small-scale, and not independently replicated in the West. It is not a treatment for atherosclerosis, high blood pressure, or blood clots, and shouldn't replace prescribed cardiovascular care.
Only the research-grade injectable powder is reconstituted — the oral capsule and sublingual drops are taken as-is and never mixed. For that powder the math is standard: a 20 mg vial + 4 mL bacteriostatic water = 5 mg/mL, so a 1 mg amount = 0.2 mL (20 units on a U-100 syringe). Commonly cited protocols circle 10 mg over ~20 days, but no injectable human dose is formally established, so any figure is a research choice, not a recommendation.
Vesugen is not FDA-approved and hasn't been evaluated by any Western regulator — it's sold as a research compound or supplement, sourced mainly through Russian channels. As a simple tripeptide it's expected to have low toxicity and no significant adverse effects are reported in Russian use, but no independent Western safety assessment exists, and any real vascular or cardiac condition needs proper medical care. Storage: keep capsules cool and dry; store the lyophilized injectable powder refrigerated and protected from light, and use any reconstituted solution promptly.
Practical takeaway: If your goal involves weight management, metabolic health, recovery, physical performance, cognitive function, appearance, or general well-being, discuss it with a licensed healthcare professional. They can help you evaluate approved, evidence-based options rather than relying on an unapproved or investigational compound. This calculator is intended only for transparent research-reference calculations and does not determine an appropriate amount, recommend use, or replace professional medical guidance.

About the author

Maria Hrabina is a pharmacist and scientific reviewer with a strong interest in peptide science, pharmacology, and emerging therapeutic compounds.

Her work focuses on understanding how peptide-based compounds interact with biological signaling pathways and how they are being investigated across areas such as metabolic health, dermatology, recovery, regenerative research, and pharmaceutical development.

Maria follows research on a broad range of peptides, from compounds used in approved medicines to experimental molecules still being evaluated in laboratory, preclinical, and clinical studies.

Her approach combines scientific curiosity with critical evaluation of evidence. She believes promising mechanisms and early research deserve attention, but should not be presented as established clinical benefits until they are supported by adequate human data.

Her areas of focus include scientific literature review, mechanisms of action, pharmacology, pharmacokinetics, safety, pharmaceutical formulation, and the overall quality of evidence behind peptide-based compounds.

She is particularly interested in the process of translating an experimental molecule into a reliable pharmaceutical product — including compound characterization, purity, stability, formulation, dose selection, safety assessment, and controlled clinical trials.

Maria believes peptide science has significant long-term potential, but that its progress depends on rigorous research, high manufacturing standards, transparent safety data, and responsible scientific communication.

Through her writing, she aims to help readers understand both sides of peptide research: what makes these compounds scientifically promising and what questions remain before their potential can be considered clinically established.

Areas of interest: Peptide Science · Therapeutic Peptides · Peptide Pharmacology · Metabolic Peptides · Cosmetic Peptides · Drug Development · Pharmacokinetics · Drug Safety · Pharmaceutical Formulation · Emerging Therapies · Evidence-Based Medicine

Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.
← All peptides